444 related articles for article (PubMed ID: 35637953)
1. The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers.
Zhang Q; Chen WW; Sun X; Qian D; Tang DD; Zhang LL; Li MY; Wang LY; Wu CJ; Peng W
Int J Biol Sci; 2022; 18(8):3498-3527. PubMed ID: 35637953
[TBL] [Abstract][Full Text] [Related]
2. Emodin - A natural anthraquinone derivative with diverse pharmacological activities.
Semwal RB; Semwal DK; Combrinck S; Viljoen A
Phytochemistry; 2021 Oct; 190():112854. PubMed ID: 34311280
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, Molecular Docking, and Biological Evaluation of New Emodin Anthraquinone Derivatives as Potential Antitumor Substances.
Li Y; Guo F; Chen T; Zhang L; Wang Z; Su Q; Feng L
Chem Biodivers; 2020 Sep; 17(9):e2000328. PubMed ID: 32627416
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: roles of apoptotic cell death and LS1034 tumor xenografts model.
Ma YS; Weng SW; Lin MW; Lu CC; Chiang JH; Yang JS; Lai KC; Lin JP; Tang NY; Lin JG; Chung JG
Food Chem Toxicol; 2012 May; 50(5):1271-8. PubMed ID: 22321733
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53.
Kamil M; Haque E; Mir SS; Irfan S; Hasan A; Sheikh S; Alam S; Ansari KM; Nazir A
Anticancer Agents Med Chem; 2019; 19(2):184-193. PubMed ID: 30370860
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo.
Chun-Guang W; Jun-Qing Y; Bei-Zhong L; Dan-Ting J; Chong W; Liang Z; Dan Z; Yan W
Eur J Pharmacol; 2010 Feb; 627(1-3):33-41. PubMed ID: 19857484
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, SAR and pharmacological characterization of novel anthraquinone cation compounds as potential anticancer agents.
Zheng Y; Zhu L; Fan L; Zhao W; Wang J; Hao X; Zhu Y; Hu X; Yuan Y; Shao J; Wang W
Eur J Med Chem; 2017 Jan; 125():902-913. PubMed ID: 27769031
[TBL] [Abstract][Full Text] [Related]
8. Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer.
Şeker Karatoprak G; Küpeli Akkol E; Yücel Ç; Bahadır Acıkara Ö; Sobarzo-Sánchez E
Oxid Med Cell Longev; 2022; 2022():7928200. PubMed ID: 35087619
[TBL] [Abstract][Full Text] [Related]
9. Emodin Induces Apoptosis of Colon Cancer Cells via Induction of Autophagy in a ROS-Dependent Manner.
Wang Y; Luo Q; He X; Wei H; Wang T; Shao J; Jiang X
Oncol Res; 2018 Jul; 26(6):889-899. PubMed ID: 28762328
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Emodin for Gastrointestinal Cancers.
McDonald SJ; VanderVeen BN; Velazquez KT; Enos RT; Fairman CM; Cardaci TD; Fan D; Murphy EA
Integr Cancer Ther; 2022; 21():15347354211067469. PubMed ID: 34984952
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.
Lee KH; Lee MS; Cha EY; Sul JY; Lee JS; Kim JS; Park JB; Kim JY
Mol Med Rep; 2017 Apr; 15(4):2163-2173. PubMed ID: 28260110
[TBL] [Abstract][Full Text] [Related]
12. The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb-A Summary Update.
Stompor-Gorący M
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502424
[TBL] [Abstract][Full Text] [Related]
13. Emodin azide methyl anthraquinone derivative induced G0/ G1 arrest in HER2/neu-overexpressing MDA-MB-453 breast cancer cells.
Yan YY; Fu LW; Zhang W; Ma HS; Ma CG; Liang YJ; Liu BY; Yu JZ; Wu QZ; Dong YM
J BUON; 2014; 19(3):650-5. PubMed ID: 25261647
[TBL] [Abstract][Full Text] [Related]
14. Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu.
Yan YY; Zheng LS; Zhang X; Chen LK; Singh S; Wang F; Zhang JY; Liang YJ; Dai CL; Gu LQ; Zeng MS; Talele TT; Chen ZS; Fu LW
Mol Pharm; 2011 Oct; 8(5):1687-97. PubMed ID: 21812426
[TBL] [Abstract][Full Text] [Related]
15. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin.
Cui Y; Chen LJ; Huang T; Ying JQ; Li J
Chin J Nat Med; 2020 Jun; 18(6):425-435. PubMed ID: 32503734
[TBL] [Abstract][Full Text] [Related]
16. Anticancer action of naturally occurring emodin for the controlling of cervical cancer.
Lande PS; Adhao VS; Ambhore JP; Gaikwad KP; Chandak CS; Joge LP
Explor Target Antitumor Ther; 2023; 4(4):690-698. PubMed ID: 37720346
[TBL] [Abstract][Full Text] [Related]
17. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis.
Yang J; Li H; Chen YY; Wang XJ; Shi GY; Hu QS; Kang XL; Lu Y; Tang XM; Guo QS; Yi J
Free Radic Biol Med; 2004 Dec; 37(12):2027-41. PubMed ID: 15544921
[TBL] [Abstract][Full Text] [Related]
18. Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities.
Adnan M; Rasul A; Hussain G; Shah MA; Sarfraz I; Nageen B; Riaz A; Khalid R; Asrar M; Selamoglu Z; Adem Ş; Sarker SD
Curr Drug Targets; 2021; 22(5):488-504. PubMed ID: 33050858
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect of emodin on gynecological cancer cells.
Wang Y; Yu H; Zhang J; Ge X; Gao J; Zhang Y; Lou G
Cell Oncol (Dordr); 2015 Oct; 38(5):353-63. PubMed ID: 26162964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
